Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedNew help and navigation items were added to the page: No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment section label, while the older Intervention / Treatment label was removed. The revision badge changed from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.5%

- Check8 days agoChange DetectedThe page revision tag was updated to v3.5.5, indicating a newer version of the entry has been published.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new page build. It does not modify the study details themselves.SummaryDifference0.1%

- Check51 days agoChange DetectedClinicalTrials.gov page footer revision updated from v3.5.2 to v3.5.3, indicating a platform/build version change rather than substantive study information.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedThe revision tag on the page has been updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.